Doctor & Staff Disclosures

We want to share information regarding our relationships with orthopedic device and pharmaceutical companies. Each of our doctors is a member of the American Academy of Orthopaedic Surgeons (AAOS) or the American College of Foot and Ankle Surgeons. Both organizations hold members to extremely high ethical standards to ensure that even the appearance of a conflict of interest does not jeopardize the trust that you place in our doctors. Our center adheres to the AAOS Standards of Professionalism that require doctors to identify and disclose potential conflicts of interest to their patients, the public and colleagues. You can learn more about these Standards of Professionalism at the AAOS website.

We receive financial support from companies for our annual educational course, the Baltimore Limb Deformity Course.

Our physicians have been active in their careers with the research and development of new devices, surgical instruments and techniques. We use research funding from companies to conduct studies that help us improve patient care. Some of our physicians work under contract with orthopedic companies, providing consulting services on new products and input on research and development. In return for this time and expertise, some of our physicians receive compensation in the form of a consulting fee, stock options or royalties.

We use products from these companies in the care of patients, but we also use similar products from other manufacturers. We want to assure you that the selection of which product to use in your care – and the care of all of our patients – is based only on what is best for you, not on which company makes the product. It is important that you are aware of these relationships with device manufacturers, understand that we put the interests of patients first, and know that we are available to answer any questions that you may have.

The disclosures listed below have occurred within the last 12 months:

  • The following companies supported our institution’s annual course (the Baltimore Limb Deformity Course) for orthopedic surgeons:
    • Arthrex
    • Clubfoot Solutions
    • DePuy Synthes
    • NuVasive Specialized Orthopedics
    • Orthofix
    • OrthoPediatrics
    • Paragon 28
    • Smith+Nephew
    • Stryker
    • WishBone Medical
  • Disclosures that are specific to members of our medical team:
    • Dr. Philip K. McClure:
      • DePuy Synthes (consultant)
      • Novadip (consultant)
      • NuVasive Specialized Orthopedics (consultant)
      • Orthofix (consultant)
      • Smith+Nephew (consultant)
      • WishBone (unpaid consultant)
    • Dr. John E. Herzenberg:
      • NuVasive Specialized Orthopedics (consultant)
      • OrthoPediatrics (consultant)
      • Orthofix (consultant)
      • NuVasive Specialized Orthopedics (consultant)
      • Smith+Nephew (consultant)
      • WishBone Medical (consultant)
    • Dr. Shawn C. Standard:
      • NuVasive Specialized Orthopedics (consultant, royalties)
      • Pega Medical (consultant, royalties)
      • Smith+Nephew (consultant, royalties)
      • WishBone Medical (consultant, royalties)
    • Dr. Janet D. Conway:
      • Biocomposites (fellowship support)
      • Bonesupport (consultant)
      • Johnson & Johnson
      • MicroGenDX (Advisory Board)
      • Orthofix (consultant)
      • Smith+Nephew (consultant)
    • Dr. Michael J. Assayag:
      • Johnson & Johnson (unpaid consultant)
      • OrthoPediatrics (unpaid consultant)
      • Orthofix (unpaid consultant)
    • Dr. Christopher Bibbo:
      • No disclosures
    • Dr. Noman A. Siddiqui:
      • Arthrex (consultant)
    • Anil Bhave, PT:
      • CyMedica Orthopedics (stock ownership)
      • Emovi and KneeKG Systems (key opinion leader)
      • Mirror AR (stock ownership)
      • Moderna (stock ownership)
      • Pfizer (stock ownership)